Psychopharmacology in Medical Conditions · Renal Safety

How Do I Dose Gabapentin and Pregabalin in Kidney Disease?

Gabapentinoids invert almost everything else about renal prescribing. There is no hepatic escape hatch — both gabapentin and pregabalin are cleared almost entirely by the kidney, unchanged — so the dose isn’t chosen by judgment, it’s read off a table indexed to renal function. Here are the questions busy prescribers ask most, answered.

The 30-second version

The dose is the creatinine clearance. Both are cleared almost entirely by the kidney, unchanged, so clearance falls in lockstep with CrCl — a “normal” dose in CKD is an accumulation event waiting to happen.
They break the dialysis rule. HD removes a large fraction of the drug, so dialysis patients need a supplemental dose after each session, not a withheld one.
The tell of toxicity is neurologic. New myoclonus, ataxia, or confusion on a gabapentinoid is accumulation until proven otherwise.
The opioid combination is the killer. The FDA warns of fatal respiratory depression, concentrated in renal impairment, the elderly, and opioid co-use.
Don’t miss the class suicidality warning — and taper, never stop abruptly.

Do gabapentin and pregabalin really need renal dose adjustment?

Yes — more than almost any psychotropic. Both are excreted unchanged with essentially no metabolism, so clearance falls in lockstep with CrCl. Gabapentin’s half-life shows it plainly:

Gabapentin half-life by renal function
Renal function	Gabapentin half-life
Normal	~6.5 hours
CrCl < 30	~52 hours
Anuric (between HD sessions)	~132 hours

A “normal” dose in CKD is an accumulation event waiting to happen — read it off the table, don’t titrate by feel.

What are the renal dose bands?

Gabapentin total daily dose by renal function (FDA label)
CrCl (mL/min)	Gabapentin total daily dose
≥ 60	900–3600 mg/day (300–1200 mg three times daily)
30–59	400–1400 mg/day (twice daily)
15–29	200–700 mg/day (once daily)
< 15	100–300 mg/day (once daily; reduce proportionally further below 15)
Haemodialysis	Dose per band plus a supplement after each 4-hour session, matched to the maintenance-dose tier (125–350 mg)

Pregabalin tells the same story with cleaner pharmacokinetics (~90% excreted unchanged, but linear absorption, so more predictable), with its own band table from 150–600 mg/day at CrCl ≥ 60 down to 25–75 mg/day below CrCl 15, plus a post-dialysis supplement. The full pregabalin bands and HD supplement schedule are in the chapter.

Watch the estimate you dose from. Both labels define their bands in Cockcroft-Gault CrCl, not the CKD-EPI eGFR your lab reports. A patient straddling CrCl 30 or 15 can land in a different row depending on which number you use — confirm it before you commit, especially in the small, elderly, or low-muscle-mass patient.

Are gabapentinoids removed by dialysis — and do I supplement after a session?

Yes — and the order has two parts most prescribers get half-right. Both are well removed by haemodialysis — pregabalin by about half in a single 4-hour run.

The two-part haemodialysis order
Step	What to do
1. Reduce	Drop the daily dose to the CrCl band — skip this and they accumulate between runs
2. Supplement	Add an extra dose right after each session — skip this and they swing sub-therapeutic
Start point	The floor of the band, not the ceiling

In dialysis patients, even low doses tracked with more altered mental status and falls (dose-dependently), and the gabapentinoid–opioid combination carried higher mortality than opioids alone.

Gabapentin or pregabalin — which is better in renal impairment?

Neither escapes the kidney — both need band dosing and both accumulate. The practical differences:

Gabapentin vs pregabalin in renal impairment
	Gabapentin	Pregabalin
Absorption	Saturable — high doses give diminishing returns	Linear — predictable exposure
Renal clearance	Unchanged, tracks CrCl	~90% unchanged, tracks CrCl
Scheduling	Not federal (some states)	Schedule V
Pick on	Same renal dosing discipline either way — choose by predictability vs misuse concern

Formulation trap: extended-release pregabalin is not for CrCl < 30 or dialysis — use immediate-release.

What does gabapentinoid toxicity look like in a CKD patient?

It’s neurologic — and easy to blame on the kidney instead of the drug.

The renal toxidrome — and why it gets missed
Sign	Why it matters
Sedation, dizziness, ataxia	Common, dose-related; the fall risk in an elderly CKD patient is the real harm
Myoclonus / asterixis	The early tell of accumulation — new jerks are a dose signal, not background CKD
Confusion / encephalopathy	Mimics uremic encephalopathy and gets blamed on the kidney
Peripheral edema, weight gain	Relevant in heart failure and fluid-overloaded CKD

The rule: treat new neurologic signs — especially myoclonus — as accumulation until proven otherwise.

What’s the most dangerous interaction?

Opioids and other CNS depressants — a class effect that renal impairment amplifies, not a renal mechanism.

FDA warning. Gabapentinoids can cause serious, life-threatening, or fatal respiratory depression. Treat a gabapentinoid added on top of an opioid as a deliberate decision with counseling and a low starting dose, not a benign adjunct; if respiratory reserve is poor, reconsider the agent.

Where the risk concentrates
Risk factor	Why it stacks
On opioids / CNS depressants	Additive respiratory depression
Elderly	Reduced physiologic reserve
Respiratory disease	Less margin to begin with
Renal impairment	Accumulation drives exposure

An older CKD patient on an opioid for pain carries all four at once — the textbook high-risk profile.

Anything a psychiatric prescriber specifically shouldn’t miss?

Two things that have nothing to do with the kidney.

Two psychiatry-specific watch-outs
Watch-out	What to do
Suicidality (FDA class warning, any indication)	Counsel patient and family; watch mood, especially the first weeks and after dose changes — CKD already carries a high depression burden
Withdrawal on abrupt stop	Anxiety, insomnia, sweating, even seizures — taper, don’t discontinue cold

That’s the field guide. The full chapter adds the complete pregabalin bands, the haemodialysis supplement schedule, the action ladder, a patient-counseling script, and an EMR documentation template.

Part of: Psychopharmacology with Renal Impairment

This is one chapter. The full course covers dosing by eGFR across every drug class, dialysis, transplant, and a point-of-care quick-reference table — every dose verified against current FDA labeling. Two chapters are free; membership opens the rest.

Start here: the framework

The Renal Decision FrameworkFree

Mood stabilizers

Lithium in CKD: DosingFree Lithium Toxicity: Recognition & High-Risk InteractionsMembers Mood Stabilizers Beyond LithiumMembers

Antidepressants & antipsychotics

Antidepressants in Renal ImpairmentMembers Antipsychotics in Renal ImpairmentMembers

Sedatives, stimulants & pain agents

Gabapentinoids in Renal ImpairmentMembers Benzodiazepines & Sedative-HypnoticsMembers Stimulants & ADHD MedicationsMembers

Special settings & quick reference

Psychotropic Dosing in Dialysis (HD & PD)Members Psychotropics in Renal Transplant PatientsMembers Renal Quick-Reference Dosing TableMembers

Explore the full course →

Not a member yet? View membership options →

The Rapid Decision Series

Prescribing psychotropics safely across medical comorbidities — Cardiac and Renal are live, with more on the way.

See the full series →

Student & resident discounts available — email your program details to [email protected]. Educational content only; it supports, and does not replace, individual clinical judgment and current prescribing information.